Literature DB >> 2548189

Translation of glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA is increased in poliovirus-infected cells at a time when cap-dependent translation of cellular mRNAs is inhibited.

P Sarnow1.   

Abstract

All cellular cytoplasmic mRNAs carry a 7-methylguanylate cap attached to their 5' ends. This cap structure is recognized by cap-binding proteins that then direct the binding of ribosomal subunits to this 5'-end complex. Poliovirus, a plus-stranded RNA virus, interferes with this cellular translation process by proteolytically inactivating the cap-binding protein complex. Subsequently the viral mRNA can be translated by an initiation process in which ribosomes bind internally to the mRNA [Pelletier, J. & Sonenberg, N. (1988) Nature (London) 334, 320-325], obviating cap-dependent translation. At least one cellular mRNA, encoding a heat shock-like protein, glucose-regulated protein 78/immunoglobulin heavy-chain binding protein, has been discovered to be translated at an increased rate in poliovirus-infected cells at a time when the translation of other cellular mRNAs is inhibited. The glucose-regulated protein 78/immunoglobulin heavy-chain binding protein mRNA thus exemplifies a cellular mRNA that is translated at a specifically enhanced rate by an as-yet-unresolved cap-independent initiation process in cells when the cap-binding protein complex is not functional.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548189      PMCID: PMC297717          DOI: 10.1073/pnas.86.15.5795

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Capped mRNAs with reduced secondary structure can function in extracts from poliovirus-infected cells.

Authors:  N Sonenberg; D Guertin; K A Lee
Journal:  Mol Cell Biol       Date:  1982-12       Impact factor: 4.272

2.  Infection with paramyxoviruses stimulates synthesis of cellular polypeptides that are also stimulated in cells transformed by Rous sarcoma virus or deprived of glucose.

Authors:  R W Peluso; R A Lamb; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

3.  An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger RNA.

Authors:  L T Chow; R E Gelinas; T R Broker; R J Roberts
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

Review 4.  Regulation of translation by poliovirus.

Authors:  N Sonenberg
Journal:  Adv Virus Res       Date:  1987       Impact factor: 9.937

5.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

6.  Primary structure, gene organization and polypeptide expression of poliovirus RNA.

Authors:  N Kitamura; B L Semler; P G Rothberg; G R Larsen; C J Adler; A J Dorner; E A Emini; R Hanecak; J J Lee; S van der Werf; C W Anderson; E Wimmer
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

7.  Highly conserved glucose-regulated protein in hamster and chicken cells: preliminary characterization of its cDNA clone.

Authors:  A S Lee; A Delegeane; D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

8.  In cultured chick embryo fibroblasts the hexose transport components are not the 75 000 and 95 000 dalton polypeptides synthesized following glucose deprivation.

Authors:  C A Zala; M Salas-Prato; W T Yan; B Banjo; J F Perdue
Journal:  Can J Biochem       Date:  1980-10

9.  Spliced segments at the 5' terminus of adenovirus 2 late mRNA.

Authors:  S M Berget; C Moore; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

10.  Simian virus 40 tandem repeated sequences as an element of the early promoter.

Authors:  P Gruss; R Dhar; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  56 in total

1.  Effect of intercistronic length on internal ribosome entry site (IRES) efficiency in bicistronic mRNA.

Authors:  J Attal; M C Theron; C Puissant; L M Houdebine
Journal:  Gene Expr       Date:  1999

2.  La autoantigen enhances translation of BiP mRNA.

Authors:  Y K Kim; S H Back; J Rho; S H Lee; S K Jang
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

3.  Translational enhancement of the poliovirus 5' noncoding region mediated by virus-encoded polypeptide 2A.

Authors:  S J Hambidge; P Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

4.  Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5' noncoding region.

Authors:  J R Gebhard; E Ehrenfeld
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

5.  Internal entry of ribosomes on a tricistronic mRNA encoded by infectious bronchitis virus.

Authors:  D X Liu; S C Inglis
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 6.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

7.  Conservation of RNA-protein interactions among picornaviruses.

Authors:  S L Dildine; B L Semler
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

8.  Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex.

Authors:  P J Dolph; J T Huang; R J Schneider
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

9.  BiP internal ribosomal entry site activity is controlled by heat-induced interaction of NSAP1.

Authors:  Sungchan Cho; Sung Mi Park; Tae Don Kim; Jong Heon Kim; Kyong-Tai Kim; Sung Key Jang
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

10.  Poliovirus infection enhances the formation of two ribonucleoprotein complexes at the 3' end of viral negative-strand RNA.

Authors:  H H Roehl; B L Semler
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.